Sonoma Pharmaceuticals
SNOA
21 hedge funds and large institutions have $1.82M invested in Sonoma Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
587% more capital inflows, than outflows
Capital inflows: $419K | Capital outflows: $60.9K
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
31% more funds holding
Funds holding: 16 → 21 (+5)
1.83% more ownership
Funds ownership: 6.73% → 8.56% (+1.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Investors US
Denver,
Colorado
|
+$124K |
| 2 |
Renaissance Technologies
New York
|
+$63K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58.9K |
| 4 |
Raymond James & Associates
St Petersburg,
Florida
|
+$50.6K |
| 5 |
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$48.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$47K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9.9K |
| 3 |
Tower Research Capital (TRC)
New York
|
-$2K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| 5 |
Wealthspire Advisors (Maryland)
Potomac,
Maryland
|
-$1K |
SNOA Hedge Fund Activity: Q4 2016 in Review
21 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q4 2016, worth a combined $1.82M — up 48% from $1.23M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new SNOA positions and 5 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $124K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $47K sold.
- 21 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q4 2016, up from 16 in Q3 2016.
- Funds reported $1.82M of Sonoma Pharmaceuticals stock for Q4 2016, up 48% quarter-over-quarter.
- 10 funds opened new Sonoma Pharmaceuticals positions in Q4 2016 and 5 closed out, a net change of +5 holders.
- The largest Sonoma Pharmaceuticals buyer in Q4 2016 was Janus Henderson Investors US, an estimated $124K added.
- The largest Sonoma Pharmaceuticals seller in Q4 2016 was Susquehanna International Group, an estimated $47K sold.
Based on aggregated 13F filings for Q4 2016.